About Chr. Hansen
Chr. Hansen is a company based in Copenhagen (Denmark) founded in 1843 was acquired by PAI Partners in May 2005. The company has 122 employees as of December 31, 2024. Chr. Hansen has completed 8 acquisitions, including ASTARTE Probiotics, Bovamine and GangaGen.
- Headquarter Copenhagen, Denmark
- Employees 122 as on 31 Dec, 2024
- Stage Public
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chr.Hansen (India) Private Limited
- Date of Incorporation 16 Jan, 2004
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$147.2 M (USD)-3.37as on Dec 31, 2024
-
Net Profit
$25.97 M (USD)-14.8as on Dec 31, 2024
-
EBITDA
$29.41 M (USD)-11.04as on Dec 31, 2024
-
Latest Funding Round
$193.08 K (USD), Post-IPO
Nov 22, 2022
-
Investors
European Investment Bank
& 4 more
-
Employee Count
122
as on Dec 31, 2024
-
Investments & Acquisitions
ASTARTE Probiotics
& 7 more
-
Acquired by
PAI Partners
(May 01, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Chr. Hansen
Chr. Hansen is a publicly listed company on the NASDAQ with ticker symbol CHR in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Chr. Hansen
Unlock access to complete
Software Development Team
106 people
Sales and Marketing
75 people
Senior Team
68 people
Leadership Team
58 people
Head Team
43 people
Product Management Team
35 people
Human Resources and Administration
24 people
Finance and Accounting
22 people
Unlock access to complete
Funding Insights of Chr. Hansen
Investors in Chr. Hansen
Chr. Hansen has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, European Union and NAXS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed across the Nordic region.
|
Locked | Locked | Locked | |
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Private investment firm specializing in markets and partnerships.
|
Locked | Locked | Locked |
Investor details for Chr. Hansen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chr. Hansen
Chr. Hansen has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include ASTARTE Probiotics, Bovamine and GangaGen.
Investment portfolio details for Chr. Hansen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Probiotic feed solutions for livestock are developed and marketed.
|
Locked | Locked | 2010 | Locked | |
|
Probiotic supplements for women's vaginal health are provided.
|
Locked | Locked | 2007 | Locked | |
|
Provider of nutritional, pharmaceutical, cosmetic and medical applications product development & research services
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Chr. Hansen
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Chr. Hansen
Detailed financials for Chr. Hansen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chr. Hansen Comparisons
Peer comparison for Chr. Hansen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chr. Hansen
Detailed competitors of Chr. Hansen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chr. Hansen
Complete news archive for Chr. Hansen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chr. Hansen
Chr. Hansen was founded in 1843 and raised its 1st funding round 162 years after it was founded.
Chr. Hansen is headquartered in Copenhagen, Denmark.
As of Dec 31, 2024, the latest employee count at Chr. Hansen is 122.
Annual revenue of Chr. Hansen is $147.2M as on Dec 31, 2024.
Developer of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. They develop products based on microbial strains. The food cultures enzymes division provides products such as cheese, meat, and plant fermented bases. Its Health and Nutrition division provides probiotic cultures for dietary supplements, over-the-counter pharmaceuticals, infant formula, animal feed, and plant protection industries. The companys Natural Colors division offers natural color solutions for the food industries, including the beverage, confectionery, ice cream, dairy, fruit preparation, and prepared food segments.
Yes, Chr. Hansen is publicly traded on NASDAQ under the ticker symbol CHR.
Chr. Hansen has made 8 acquisitions, including ASTARTE Probiotics, Bovamine, and GangaGen.
Chr. Hansen has 5 investors. Key investors include European Investment Bank, European Union, NAXS, Ardian, and PAI Partners.
The ticker symbol of Chr. Hansen is CHR on NASDAQ.